NIH-funded research R01 grant

Understanding how bacterial channels respond to mechanical forces

Official title: Elucidating the gating mechanisms of bacterial mechanosensitive channels

Funded at Rockefeller University · NIH-10986103 · Data updated 2026-11-12

This study is looking at how tiny channels in bacteria respond to pressure, which helps them survive, and by understanding how these channels work, researchers hope to find new ways to create antibiotics that specifically target bacteria without affecting humans.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionRockefeller University
NIH-funded
Lab location1 site (New York, United States)
Project startJanuary 1, 2023
Project endNovember 30, 2026
Funding year2025
Award (this year)$425,434
NIH project number5R01GM144581-03
Project IDNIH-10986103 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for benefiting from this research would be individuals with bacterial infections that are resistant to current antibiotic treatments.

Less likely to help

Patients with viral infections or non-bacterial conditions are unlikely to benefit from this research.

What this research studies

This research investigates how mechanosensitive channels in bacteria open in response to mechanical forces, which is crucial for their survival. By studying these channels, researchers aim to uncover the mechanisms that control their opening and closing, which could lead to new antibiotic treatments. The approach involves advanced techniques like cryo-electron microscopy to visualize the channels in different states. This research is particularly significant because these channels are not present in humans, making them unique targets for drug development.

Why it matters

Potential benefit: If successful, this research could lead to the development of novel antibiotics that specifically target bacterial mechanosensitive channels.

How similar studies have gone: Other research has shown promise in targeting bacterial channels for antibiotic development, indicating that this approach has potential for success.

Where this research is happening

  • Rockefeller University
    New York, United States
    Active

Researchers

  • Principal investigator: Walz, Thomas — Rockefeller University
  • Study coordinator: Walz, Thomas

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.